目前关于为 mitra 缺陷进行 mitra 膜重建的概念
A C Galloway1, S B Colvin, F G Baumann
1Department of Surgery, New York University Medical Center, New York 10016.
Circulation
|November 1, 1988
概括
使用卡蒂尔技术进行关节重建,为关节缺陷提供了持久且安全的外科选择. 这种方法可能会成为首选的治疗方法,特别是对于退行性心肌膜疾病.
科学领域:
- 心血管外科心血管外科
- 心脏门维修 心脏门维修
- 医疗技术 医疗技术 医学技术
背景情况:
- 假肢和生物假肢膜日益增长的局限性需要替代解决方案.
- 由于门置换的缺点,对手术中额头门重建的兴趣再次增加.
- 需要长期的功能性数据,关于中枢重建技术.
研究的目的:
- 评估当前的状态和中枢重建的长期结果.
- 评估卡蒂尔部重建技术的适用性,耐用性和并发症率.
- 确定额头骨重建作为额头骨缺陷的主要外科选择的潜力.
主要方法:
- 对148名接受 mitra 重建的患者进行后续研究.
- 在患者队列中包括晚期功能数据.
- 综合审查现有的关于关节重建的文献.
主要成果:
- 卡潘蒂耶部重建是广泛适用的,并证明了耐用性.
- 这种手术的并发症率很低.
- 值得注意的是,没有晚期血栓栓塞和抗凝药并发症.
结论:
- 中心门重建为门更换提供了一个安全有效的替代方案.
- 该技术的耐用性和低并发症概况支持其使用.
- 较早的干预与 mitrale 重建可以防止心肌损伤在 mitrale 缺陷患者.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


